Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
glaw-KOH-muh secondary to sfer-oh-FAY-kee-uh/ek-TOH-pee-uh LEN-tis and meg-uh-loh-KOR-nee-uh
Also known as: Spherophakia-associated glaucoma, Megalocornea-related glaucoma
At a Glance
What is Glaucoma secondary to spherophakia/ectopia lentis and megalocornea?
This condition is a type of glaucoma that occurs due to abnormalities in the eye's lens and cornea. It primarily affects the eyes, leading to increased intraocular pressure. The condition is caused by genetic mutations that affect the structural integrity of the eye. Over time, the increased pressure can damage the optic nerve, leading to vision loss. Early symptoms may include blurred vision and eye pain, while late symptoms can progress to significant vision impairment. Early diagnosis is critical to prevent irreversible vision damage. It can have a significant impact on family life, requiring regular medical appointments and potential surgical interventions. The prognosis varies, but early treatment can help manage symptoms and preserve vision. Daily life for affected individuals may involve visual aids and adaptations to accommodate vision limitations. The condition can be challenging, but with proper management, individuals can lead fulfilling lives. Family support and genetic counseling are important aspects of managing the condition.
Medical Definition
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea is characterized by increased intraocular pressure due to lens dislocation and enlargement of the cornea. Pathologically, it involves weakness of the zonules and lens instability, leading to lens-induced angle closure. Histological findings may include abnormal lens shape and corneal enlargement. The condition is classified under secondary glaucomas due to lens abnormalities. Epidemiologically, it is a rare disorder with autosomal recessive inheritance, often linked to mutations in the LTBP2 gene. The disease course involves progressive optic nerve damage if untreated, necessitating early intervention to prevent vision loss.
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Elevated intraocular pressure manifests as a gradual increase in pressure within the eye, often without initial symptoms. This occurs due to impaired drainage of aqueous humor, exacerbated by lens displacement in spherophakia or ectopia lentis. Over time, increased pressure can damage the optic nerve, leading to vision loss if untreated. Patients may experience eye pain and headaches, and regular monitoring and medication can help manage pressure levels.
Vision impairment presents as blurred or reduced vision, often worsening over time. It is caused by lens dislocation or deformation, which disrupts the normal focusing mechanism of the eye. As the condition progresses, patients may experience difficulty with daily activities such as reading or driving. Corrective lenses or surgical interventions may be necessary to improve vision.
Corneal enlargement, or megalocornea, is characterized by an abnormally large corneal diameter. This occurs due to genetic mutations affecting the structural proteins of the eye, leading to weakened corneal integrity. Over time, the enlarged cornea can cause refractive errors and increased light sensitivity. Patients may require protective eyewear and regular eye exams to monitor changes.
Common
Lens subluxation is the partial displacement of the lens from its normal position. This results from weakened zonules, the fibers that hold the lens in place, often due to genetic mutations. As subluxation progresses, it can lead to significant visual disturbances and increased risk of glaucoma. Surgical intervention may be necessary to reposition or replace the lens.
Photophobia is an increased sensitivity to light, causing discomfort or pain in bright environments. It occurs due to corneal abnormalities and lens dislocation, which affect light transmission through the eye. Over time, photophobia can limit outdoor activities and affect quality of life. Wearing sunglasses and avoiding bright lights can help manage symptoms.
Astigmatism presents as distorted or blurred vision at all distances. It is caused by irregular curvature of the cornea or lens, often associated with megalocornea or lens displacement. As astigmatism progresses, it can interfere with tasks requiring clear vision, such as reading or using a computer. Corrective lenses or refractive surgery may be recommended to improve vision clarity.
Less Common
Eye pain can manifest as a dull ache or sharp discomfort within or around the eye. It is often a result of elevated intraocular pressure or lens dislocation causing strain on ocular structures. Over time, persistent eye pain can lead to headaches and decreased quality of life. Pain management and treatment of the underlying cause are essential for relief.
Nausea may occur as a secondary symptom to severe eye pain or headaches associated with elevated intraocular pressure. The physiological stress and discomfort from ocular pressure changes can trigger nausea. If untreated, it can lead to decreased appetite and weight loss. Addressing the primary ocular issues and symptomatic treatment can alleviate nausea.
What Causes Glaucoma secondary to spherophakia/ectopia lentis and megalocornea?
The condition is primarily caused by mutations in the LTBP2 gene, located on chromosome 14q24.3. LTBP2 encodes the latent transforming growth factor-beta binding protein 2, which is crucial for the proper assembly and function of elastic fibers in the extracellular matrix. Mutations in LTBP2 can lead to structural changes that impair its ability to bind to transforming growth factor-beta (TGF-beta), disrupting the regulation of TGF-beta signaling. This disruption affects cellular processes such as proliferation and differentiation, leading to abnormal development of ocular structures. The dysfunction of elastic fibers compromises the integrity of the lens zonules, resulting in lens dislocation or ectopia lentis. Additionally, the altered extracellular matrix can affect the corneal structure, contributing to megalocornea. The dysregulation of TGF-beta signaling may also trigger an inappropriate immune response, leading to neuroinflammation. This inflammation can exacerbate damage to ocular tissues, including the optic nerve, contributing to glaucoma. The degeneration of optic nerve fibers results in progressive vision loss, a hallmark of glaucoma. Symptoms appear in a pattern based on the specific ocular structures affected, such as lens dislocation leading to secondary glaucoma. Variability in disease severity among patients can be attributed to differences in the specific mutations in LTBP2 and their effects on protein function, as well as environmental factors and genetic modifiers.
How is Glaucoma secondary to spherophakia/ectopia lentis and megalocornea Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in early childhood when parents or caregivers notice visual abnormalities or during routine pediatric ophthalmologic examinations.
The clinician looks for signs of megalocornea, spherophakia, and lens dislocation. A detailed family history is important to identify any genetic predisposition. Physical examination may reveal enlarged corneal diameter and lens subluxation. This step helps differentiate from other congenital ocular conditions.
Ultrasound biomicroscopy or anterior segment optical coherence tomography is used. These modalities reveal lens position abnormalities and increased corneal diameter. Imaging findings confirm the diagnosis by showing characteristic features of spherophakia and megalocornea. They help exclude other causes of secondary glaucoma, such as trauma or inflammation.
Routine laboratory tests are not typically used for diagnosis. However, intraocular pressure measurement is crucial to assess glaucoma severity. Abnormal results show elevated intraocular pressure, guiding the need for immediate intervention. These findings help prioritize treatment strategies to prevent vision loss.
Genetic testing focuses on sequencing the LTBP2 gene. Null mutations or other pathogenic variants are identified. Results confirm the diagnosis by correlating clinical features with genetic findings. They provide essential information for family counseling regarding inheritance patterns and recurrence risks.
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea Treatment Options
Beta-blockers reduce intraocular pressure by decreasing aqueous humor production. Timolol is a commonly used drug in this class. Clinical evidence supports its efficacy in lowering intraocular pressure in pediatric glaucoma. Limitations include potential systemic side effects like bradycardia and respiratory issues. Careful monitoring is required to balance efficacy and safety.
Vision therapy involves exercises to improve visual skills and processing. The goal is to enhance visual acuity and binocular vision. Sessions are typically conducted weekly over several months. Measurable outcomes include improved visual tracking and coordination. Long-term benefits include better visual function and quality of life.
Surgery is indicated for significant lens dislocation causing visual impairment or glaucoma. The procedure involves removing the dislocated lens and possibly implanting an intraocular lens. Expected benefits include improved vision and reduced intraocular pressure. Surgical risks include infection, retinal detachment, and intraocular pressure spikes. Post-operative care involves regular follow-ups and possible adjunctive treatments.
The care team includes ophthalmologists, geneticists, and pediatricians. Interventions focus on optimizing visual outcomes and managing associated conditions. Psychosocial support strategies address the emotional and educational needs of the child and family. Family education covers disease understanding and management strategies. Long-term monitoring plans involve regular eye examinations and genetic counseling updates.
When to See a Doctor for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
- Sudden loss of vision — this could indicate acute glaucoma or retinal detachment, requiring immediate medical attention.
- Severe eye pain — may signal increased intraocular pressure or other serious eye conditions.
- Nausea and vomiting with eye pain — can be a sign of acute angle-closure glaucoma, which is a medical emergency.
- Blurred vision — could indicate worsening of the condition and should prompt a visit to an eye specialist.
- Halos around lights — may suggest elevated intraocular pressure and requires evaluation.
- Progressive vision loss — indicates potential damage to the optic nerve and needs timely intervention.
- Mild eye discomfort — monitor for any changes or worsening symptoms and maintain regular check-ups.
- Slightly blurred vision in the morning — observe if it persists or worsens, and ensure routine eye exams.
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea — Frequently Asked Questions
Is this condition hereditary?
This condition is inherited in an autosomal recessive pattern, meaning both copies of the gene must have mutations for the condition to manifest. If both parents are carriers, there is a 25% chance with each pregnancy for the child to be affected. De novo mutations are rare but can occur. Carrier status does not typically affect health but can influence family planning decisions. Genetic counseling is recommended for affected families to understand inheritance patterns and risks.
What is the life expectancy for someone with this condition?
Life expectancy is generally normal if the condition is managed effectively, although vision loss can impact quality of life. Early diagnosis and treatment of glaucoma can improve outcomes significantly. Mortality is not directly affected by the condition, but complications from untreated glaucoma can lead to blindness. Treatment, including regular monitoring and surgery if necessary, can prevent severe complications. Patients should have realistic expectations about the need for lifelong management and regular eye care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a comprehensive eye exam, including measurement of intraocular pressure and lens evaluation. The time from first symptoms to diagnosis can vary, often taking several months. Ophthalmologists and geneticists are typically involved in the diagnostic process. Delayed diagnosis can occur due to the rarity of the condition and overlap with other eye disorders. Genetic testing can confirm the diagnosis by identifying mutations in the LTBP2 gene.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy as a potential treatment for genetic eye conditions. Novel approaches such as targeted gene editing and stem cell therapy are under investigation. ClinicalTrials.gov is a resource for finding ongoing trials related to this condition. Patients should discuss with their doctors about eligibility for trials and potential benefits. New treatments may take several years to become widely available, depending on trial outcomes and regulatory approvals.
How does this condition affect daily life and activities?
The condition can significantly impact mobility and self-care due to vision impairment. Educational adaptations may be necessary for children with visual challenges. Social and emotional challenges include coping with vision loss and potential isolation. Family members may experience increased caregiving responsibilities and emotional stress. Supportive resources such as vision aids and counseling can greatly assist in managing daily life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Congenital megalocornea with zonular weakness and childhood lens-related secondary glaucoma - a distinct phenotype caused by recessive LTBP2 mutations.
Khan AO, Aldahmesh MA, Alkuraya FS · Mol Vis · 2011 · PMID: 22025892
- 2.LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma.
Désir J, Sznajer Y, Depasse F et al. · Eur J Hum Genet · 2010 · PMID: 20179738
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-27